Clinical and virologic course of herpes simplex genitalis.

Clinical and virologic course of herpes simplex genitalis. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Clinical and virologic course of herpes simplex genitalis. Abstract Text:

The clinical and virologic course of herpes simplex genitalis in women and men was examined in order to identify measurements useful in antiviral trials. Factors influencing the clinical course included initial disease versus recurrent disease, wet-skin versus dry-skin lesions, female versus male sex. Women with initial genital herpes had higher mean peak lesion virus titers than those with recurrent disease (10(4.5) pfu compared with 10(2.5) pfu) and excreted virus longer (13 to 15 days compared with 6 to 8 days). Men with recurrent lesions had higher mean peak virus titers than women (10(4.0) pfu compared with 10(2.5) pfu), but the duration of virus excretion was shorter (three to four days compared with six to eight days). There was pronounced variation in the clinical and virologic course of recurrent lesions among different patients and even within the same patient. These observations indicate several difficulties that must be considered in conducting careful antiviral trials in patients with herpes simplex genitalis.

Clinical and virologic course of herpes simplex genitalis. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Clinical and virologic course of herpes simplex genitalis. Journal Published:

PUBLICATION TYPE: Research Support, U.S. Gov't,

Journal: The Western journal of medicine

VOLUME: 130

Page Numbers: 414-21

Journal Abbreviation: West. J. Med.

ISSN: 0093-0415

DAY: 4

MONTH: May

YEAR: 1979

Clinical and virologic course of herpes simplex genitalis. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 410504

Clinical and virologic course of herpes simplex genitalis. Keywords Mesh Terms:

KEYWORDS: Simplexvirus

MESH TERMS: isolation & purification

Chemical & Substance for Abstract: Clinical and virologic course of herpes simplex genitalis. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Clinical and virologic course of herpes simplex genitalis.

AFFILIATION:

Country: UNITED STATES

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: West J Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Clinical and virologic course of herpes simplex genitalis Related Publications

• ACTH and cortisone in the treatment of atopic dermatitis.
• Analysis of Cortical Arrays from Tradescantia virginiana at High Resolution Reveals Discrete Microtubule Subpopulations and Demonstrates That Confocal Images of Arrays Can Be Misleading.
• Brief psychiatric rating scale for children: quantitative scoring of medical records.
• Clinical and virologic course of herpes simplex genitalis.
• Cytoskeletal thermal ratchets and cytoskeletal tensegrity: determinants of brain asymmetry and symmetry?
• Defects in tongue papillae and taste sensation indicate a problem with neurotrophic support in various neurological diseases.
• Histology of spheroidal degeneration of the cornea in Labrador.
• Identification of candidate angiogenic inhibitors processed by matrix metalloproteinase 2 (MMP-2) in cell-based proteomic screens: disruption of vascular endothelial growth factor (VEGF)/heparin affin regulatory peptide (pleiotrophin) and VEGF/Connective
• Macrophage-specific metalloelastase (MMP-12) truncates and inactivates ELR+ CXC chemokines and generates CCL2, -7, -8, and -13 antagonists: potential role of the macrophage in terminating polymorphonuclear leukocyte influx.
• Matrix Metalloproteinase Processing of CXCL11/I-TAC Results in Loss of Chemoattractant Activity and Altered Glycosaminoglycan Binding.
• Matrix metalloproteinases in periodontal tissue remodelling.
• Medical differentials with potential behavioral manifestations.
• Metadegradomics: toward in vivo quantitative degradomics of proteolytic post-translational modifications of the cancer proteome.
• Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding.
• Plant collagenase: unique collagenolytic activity of cysteine proteases from ginger.
• Potential role of tubulin acetylation and microtubule-based protein trafficking in familial dysautonomia.
• Protease research in the era of systems biology.
• Proteome-derived, database-searchable peptide libraries for identifying protease cleavage sites.
• Reflection across plant cell boundaries in confocal laser scanning microscopy.
• Research criteria for the diagnosis of depression.
• Strategies for identifying patterns of categorical variables that have diagnostic significance.
• The geographic distribution of the ACE II genotype: a novel finding.